Maxim Group initiated coverage on shares of KindlyMD (NASDAQ:NAKA – Free Report) in a research report report published on Wednesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $8.00 target price on the stock.
KindlyMD Trading Up 24.4%
Shares of NASDAQ:NAKA opened at $4.08 on Wednesday. The company has a 50 day moving average price of $9.99. The firm has a market capitalization of $1.53 billion, a PE ratio of -4.74 and a beta of 33.96. KindlyMD has a fifty-two week low of $0.65 and a fifty-two week high of $34.77.
KindlyMD (NASDAQ:NAKA – Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported ($0.34) earnings per share for the quarter. The firm had revenue of $0.41 million during the quarter. KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%.
About KindlyMD
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.
Featured Stories
- Five stocks we like better than KindlyMD
- What Does a Stock Split Mean?
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Lululemon Share Price Has Plenty of Room Left to Fall
- Growth Stocks: What They Are, What They Are Not
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
